Showing 401 - 420 results of 1,825 for search '"bowel"', query time: 0.05s Refine Results
  1. 401

    The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease by Esmail Abej, Wael El-Matary, Harminder Singh, Charles N. Bernstein

    Published 2016-01-01
    “…There was no significant difference for FCAL results by outcomes on small bowel evaluation among the 21 persons with small bowel CD. …”
    Get full text
    Article
  2. 402
  3. 403
  4. 404
  5. 405

    Predictors of Medication Adherence in Pediatric Inflammatory Bowel Disease Patients at the Stollery Children’s Hospital by L Kitney, JM Turner, D Spady, B Malik, W El-Matary, R Persad, HQ Huynh

    Published 2009-01-01
    “…BACKGROUND: Patients with inflammatory bowel disease (IBD) often do not take their medications as prescribed.…”
    Get full text
    Article
  6. 406
  7. 407
  8. 408
  9. 409
  10. 410
  11. 411

    Antineoplastic Effects of 5-Aminosalicylates and Potential Cancer Preventive Role in Inflammatory Bowel Disease by Hugh J Freeman

    Published 2004-01-01
    “…Early studies from tertiary referral centers in the United States and Europe showed that patients with long-standing and extensive inflammatory bowel disease (IBD) have an increased risk of colon cancer. …”
    Get full text
    Article
  12. 412
  13. 413
  14. 414
  15. 415

    Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease by Panu Wetwittayakhlang, Farah Albader, Petra A Golovics, Gustavo Drügg Hahn, Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Peter L Lakatos

    Published 2021-01-01
    “…The impact of COVID-19 has been of great concern in patients with inflammatory bowel disease (IBD) worldwide, including an increased risk of severe outcomes and/or possible flare of IBD. …”
    Get full text
    Article
  16. 416

    Topical steroids as alternative to systemic hormonal treatment for inflammatory bowel diseases in pediatric practice by E. N. Fedulova, O. V. Shumilova, O. V. Fedorova, O. A. Tutina, G. V. Medyantseva

    Published 2011-05-01
    “…To share experience of application of topical steroids (Budenofalk®) in children with hormone – dependent inflammatory bowel diseases (IBD) and severe side effects on a background of systemic corticosteroids (CS).Original positions. …”
    Get full text
    Article
  17. 417

    Thiamine-Reduced Fatigue in Quiescent Inflammatory Bowel Disease Is Linked to Faecalibacterium prausnitzii Abundance by Sandra Bermúdez-Sánchez, Palle Bager, Jens Frederik Dahlerup, Simon Mark Dahl Baunwall, Tine Rask Licht, Martin Steen Mortensen, Christian Lodberg Hvas

    Published 2025-01-01
    “…Background and Aims: Chronic fatigue is common in patients with inflammatory bowel disease (IBD). The gut microbiota, specifically, microbial diversity and butyrate-producing bacteria have been linked to the fatigue pathogenesis. …”
    Get full text
    Article
  18. 418
  19. 419

    Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease by Michael G. Goggins, Syed A. Shah, Jason Goh, Anil Cherukuri, Donal G. Weir, Dermot Kelleher, Nasir Mahmud

    Published 2001-01-01
    “…Background: Nitric oxide (NO) production is increased in inflammatory bowel disease (IBD), and measurement of NO metabolites may be useful for monitoring disease activity.…”
    Get full text
    Article
  20. 420

    Effects of Formal Education for Patients with Inflammatory Bowel Disease: A Randomized Controlled Trial by Barbara M Waters, Louise Jensen, Richard N Fedorak

    Published 2005-01-01
    “…BACKGROUND: Patients with inflammatory bowel disease (IBD) suffer physical dysfunction and impaired quality of life (QOL), and need frequent health care. …”
    Get full text
    Article